Individual patient data meta-analysis of discrimination of the four kallikrein panel associated with the inclusion of prostate volume.

To assess whether adding prostate volume to the kallikrein panel improves discrimination for ISUP Grade Group 2 or higher (GG2+) disease, as some men may have volume measurements available at the time of blood draw.